SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway

Abstract

Programmed cell death, including necroptosis, plays a critical role in the pathogenesis of cerebral ischemia/reperfusion injury (CIRI). Silent information regulator 1 (SIRT1) has been identified as a potential therapeutic target for CIRI, yet its precise role in regulating necroptosis remains controversial. Furthermore, the potential interaction between SIRT1 and receptor-interacting protein kinase 1 (RIP1) in this context is not fully understood. Sanpian Decoction (SPD), a classical traditional herbal formula, was previously shown to enhance SIRT1 expression in our studies. Our findings demonstrated that, both in vivo and in vitro, CIRI was associated with a decrease in SIRT1 levels and phosphorylated dynamin-related protein 1 (p-DRP1) at Ser637, alongside an increase in RIP1 and other necroptosis-related proteins. Co-immunoprecipitation and immunofluorescence analyses revealed a weakened interaction between SIRT1 and RIP1. Furthermore, abnormal mitochondrial fission and dysfunction were mediated through the phosphoglycerate mutase 5–DRP1 pathway. Notably, SPD treatment improved neurological outcomes and reversed these pathological changes by enhancing the SIRT1–RIP1 interaction. In conclusion, this study suggests that SIRT1 is a promising therapeutic target for CIRI, capable of inhibiting necroptosis and mitigating mitochondrial fission via the SIRT1–RIP1 pathway. SPD exhibits therapeutic potential by activating SIRT1, thereby attenuating necroptosis and mitochondrial fission during CIRI.

Keywords

cerebral ischemia/reperfusion injury / DRP1 / mitochondrial fission / necroptosis / RIP1 / SIRT1

References

[1] Walter K., “What is Acute Ischemic Stroke?,” Jama 327, no. 9 (2022): 885.

[2] Feigin V. L. and Owolabi M. O., “Pragmatic Solutions to Reduce the Global Burden of Stroke: A World Stroke Organization-Lancet Neurology Commission,” Lancet Neurology 22, no. 12 (2023): 1160–1206.

[3] Tsivgoulis G., Katsanos A. H., Sandset E. C., et al., “Thrombolysis for Acute Ischaemic Stroke: Current Status and Future Perspectives,” Lancet Neurology 22, no. 5 (2023): 418–429.

[4] She R., Liu D., Liao J., Wang G., Ge J., and Mei Z., “Mitochondrial Dysfunctions Induce PANoptosis and Ferroptosis in Cerebral Ischemia/Reperfusion Injury: From Pathology to Therapeutic Potential,” Frontiers in Cellular Neuroscience 17 (2023): 1191629.

[5] Liu J. F., Su G., Chen L. X., et al., “Irisin Attenuates Apoptosis Following Ischemia-Reperfusion Injury through Improved Mitochondria Dynamics and ROS Suppression Mediated through the PI3K/Akt/mTOR Axis,” Molecular Neurobiology 60, no. 8 (2023): 4261–4272.

[6] Wu X., Wei J., Yi Y., et al., “Epimedium Aqueous Extract Ameliorates Cerebral Ischemia/Reperfusion Injury Through Inhibiting ROS/NLRP3-Mediated Pyroptosis,” Antioxidants (Basel, Switzerland) 12, no. 5 (2023): 999.

[7] Flippo K. H., Gnanasekaran A., Perkins G. A., et al., “AKAP1 Protects From Cerebral Ischemic Stroke by Inhibiting Drp1-Dependent Mitochondrial Fission,” Journal of Neuroscience 38, no. 38 (2018): 8233–8242.

[8] Yuan Z. L., Mo Y. Z., Li D. L., Xie L., and Chen M. H., “Inhibition of ERK Downregulates Autophagy via Mitigating Mitochondrial Fragmentation to Protect SH-SY5Y Cells From OGD/R Injury,” Cell Communication and Signaling 21, no. 1 (2023): 204.

[9] Khoury M. K., Gupta K., Franco S. R., and Liu B., “Necroptosis in the Pathophysiology of Disease,” American Journal of Pathology 190, no. 2 (2020): 272–285.

[10] Seo J., Nam Y. W., Kim S., Oh D. B., and Song J., “Necroptosis Molecular Mechanisms: Recent Findings Regarding Novel Necroptosis Regulators,” Experimental & Molecular Medicine 53, no. 6 (2021): 1007–1017.

[11] Zhu H., Tan Y., Du W., et al., “Phosphoglycerate Mutase 5 Exacerbates Cardiac Ischemia-reperfusion Injury Through Disrupting Mitochondrial Quality Control,” Redox Biology 38 (2021): 101777.

[12] Li J., Zhang J., Zhang Y., et al., “TRAF2 Protects Against Cerebral Ischemia-Induced Brain Injury by Suppressing Necroptosis,” Cell Death & Disease 10, no. 5 (2019): 328.

[13] Herskovits A. Z. and Guarente L., “SIRT1 in Neurodevelopment and Brain Senescence,” Neuron 81, no. 3 (2014): 471–483.

[14] Nie W., Zhu H., Sun X., et al., “Catalpol Attenuates Hepatic Glucose Metabolism Disorder and Oxidative Stress in Triptolide-induced Liver Injury by Regulating the SIRT1/HIF-1α Pathway,” International Journal of Biological Sciences 20, no. 10 (2024): 4077–4097.

[15] Becatti M., Taddei N., Cecchi C., Nassi N., Nassi P. A., and Fiorillo C., “SIRT1 Modulates MAPK Pathways in Ischemic-reperfused Cardiomyocytes,” Cellular and Molecular Life Sciences 69, no. 13 (2012): 2245–2260.

[16] Ugwu F. N., Yu A. P., Sin T. K., et al., “Protective Effect of Unacylated Ghrelin on Compression-Induced Skeletal Muscle Injury Mediated by SIRT1-Signaling,” Frontiers in Physiology 8 (2017): 962.

[17] Qin K. W., Liu J. F., Wu C. L., Zhang C., and Zhou L. J., “Resveratrol Prevents Vibrio Vulnificus-Induced Sepsis by Attenuating Necroptosis,” Biomedical and Environmental Sciences 36, no. 2 (2023): 135–145.

[18] Park J., Rah S. Y., A.n HS, et al., “Metformin-Induced TTP Mediates Communication Between Kupffer Cells and Hepatocytes to Alleviate Hepatic Steatosis by Regulating Lipophagy and Necroptosis,” Metabolism 141 (2023): 155516.

[19] Nikseresht S., Khodagholi F., and Ahmadiani A., “Protective Effects of Ex-527 on Cerebral Ischemia-reperfusion Injury Through Necroptosis Signaling Pathway Attenuation,” Journal of Cellular Physiology 234, no. 2 (2019): 1816–1826.

[20] Carafa V., Nebbioso A., Cuomo F., et al., “RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer,” Clinical Cancer Research 24, no. 12 (2018): 2886–2900.

[21] Zhen-Min X. U., Min J., Xiao L., et al., “[Clinical Practice Guideline for Migraine with Traditional Chinese Medicine(Draft Version for Comments)],” Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica 45, no. 21 (2020): 5057–5067.

[22] Wu B., Rao H., Yang S., et al., “Efficacy and Safety of the Classic Chinese Herbal Prescription Sanpian Decoction on Migraine: A Meta-analysis,” Explore (New York, N.Y.) 16, no. 5 (2020): 318–327.

[23] Mei Z. G., Tan L. J., Wang J. F., Li X. L., Huang W. F., and Zhou H. J., “Fermented Chinese Formula Shuan-Tong-Ling Attenuates Ischemic Stroke by Inhibiting Inflammation and Apoptosis,” Neural Regeneration Research 12, no. 3 (2017): 425–432.

[24] Tan L., Zhang X., Mei Z., et al., “Fermented Chinese Formula Shuan-Tong-Ling Protects Brain Microvascular Endothelial Cells Against Oxidative Stress Injury,” Evidence-Based Complementary and Alternative Medicine : eCAM 2016 (2016): 5154290.

[25] Yang T., Liu X., Zhou Y., et al., “Sanpian Decoction Ameliorates Cerebral Ischemia-reperfusion Injury by Regulating SIRT1/ERK/HIF-1α Pathway Through in Silico Analysis and Experimental Validation,” Journal of Ethnopharmacology 318 (2024): 116898. Pt A.

[26] Liao S., Apaijai N., Chattipakorn N., and Chattipakorn S. C., “The Possible Roles of Necroptosis During Cerebral Ischemia and Ischemia /Reperfusion Injury,” Archives of Biochemistry and Biophysics 695 (2020): 108629.

[27] Li J., McQuade T., Siemer A. B., et al., “The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis,” Cell 150, no. 2 (2012): 339–350.

[28] Li L., Zhi D., Cheng R., Li J., Luo C., and Li H., “The Neuroprotective Role of SIRT1/PGC-1α Signaling in Limb Postconditioning in Cerebral Ischemia/Reperfusion Injury,” Neuroscience Letters 749 (2021): 135736.

[29] Li C., Wu Z., Xue H., et al., “Ferroptosis Contributes to Hypoxic-ischemic Brain Injury in Neonatal Rats: Role of the SIRT1/Nrf2/GPx4 Signaling Pathway,” CNS Neuroscience & Therapeutics 28, no. 12 (2022): 2268–2280.

[30] Yan W., Sun W., Fan J., et al., “Sirt1-ROS-TRAF6 Signaling-Induced Pyroptosis Contributes to Early Injury in Ischemic Mice,” Neuroscience Bulletin 36, no. 8 (2020): 845–859.

[31] Tang H., Wen J., Qin T., et al., “New Insights Into Sirt1: Potential Therapeutic Targets for the Treatment of Cerebral Ischemic Stroke,” Frontiers in Cellular Neuroscience 17 (2023): 1228761.

[32] Liu Z., Li C., Li Y., Yu L., and Qu M., “Propofol Reduces Renal Ischemia Reperfusion-mediated Necroptosis by Up-regulation of SIRT1 in Rats,” Inflammation 45, no. 5 (2022): 2038–2051.

[33] Zhu K., Liang W., Ma Z., et al., “Necroptosis Promotes Cell-Autonomous Activation of Proinflammatory Cytokine Gene Expression,” Cell Death & Disease 9, no. 5 (2018): 500.

[34] Udawatte D. J. and Rothman A. L., “Viral Suppression of RIPK1-Mediated Signaling,” MBio 12, no. 4 (2021): e0172321.

[35] Weindel C. G., Martinez E. L., Zhao X., et al., “Mitochondrial ROS Promotes Susceptibility to Infection via Gasdermin D-Mediated Necroptosis,” Cell 185, no. 17 (2022): 3214–3231.

[36] Deragon M. A., McCaig W. D., Truong P. V., et al., “Mitochondrial Trafficking of MLKL, Bak/Bax, and Drp1 Is Mediated by RIP1 and ROS Which Leads to Decreased Mitochondrial Membrane Integrity During the Hyperglycemic Shift to Necroptosis,” International Journal of Molecular Sciences 24, no. 10 (2023): 8609.

[37] Sun S., Li Z., Huan S., et al., “Modification of Lysine Deacetylation Regulates Curcumol-induced Necroptosis Through Autophagy in Hepatic Stellate Cells,” Phytotherapy Research 36, no. 6 (2022): 2660–2676.

[38] Wu M., Gu X., and Ma Z., “Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury,” Molecular Neurobiology 58, no. 10 (2021): 5253–5271.

[39] Qi Z., Shi W., Zhao Y., Ji X., and Liu K. J., “Zinc Accumulation in Mitochondria Promotes Ischemia-induced BBB Disruption Through Drp1-dependent Mitochondria Fission,” Toxicology and Applied Pharmacology 377 (2019): 114601.

[40] Guo H., Jiang Y., Gu Z., et al., “ZFP36 protects Against Oxygen-glucose Deprivation/Reoxygenation-induced Mitochondrial Fragmentation and Neuronal Apoptosis Through Inhibiting NOX4-DRP1 Pathway,” Brain Research Bulletin 179 (2022): 57–67.

[41] Wu Q., Liu J., Mao Z., et al., “Ligustilide Attenuates Ischemic Stroke Injury by Promoting Drp1-Mediated Mitochondrial Fission via Activation of AMPK,” Phytomedicine 95 (2022): 153884.

[42] Tang B. L., “Sirt1 and the Mitochondria,” Molecules and Cells 39, no. 2 (2016): 87–95.

[43] Sun Y., Yang Y. M., Hu Y. Y., et al., “Inhibition of Nuclear Deacetylase Sirtuin-1 Induces Mitochondrial Acetylation and Calcium Overload Leading to Cell Death,” Redox Biology 53 (2022): 102334.

[44] Yao J., Wang J., Xu Y., et al., “CDK9 inhibition Blocks the Initiation of PINK1-PRKN-mediated Mitophagy by Regulating the SIRT1-FOXO3-BNIP3 Axis and Enhances the Therapeutic Effects Involving Mitochondrial Dysfunction in Hepatocellular Carcinoma,” Autophagy 18, no. 8 (2022): 1879–1897.

[45] Tang J., Chen Y., Li J., et al., “14, 15-EET Alleviates Neurological Impairment Through Maintaining Mitochondrial Dynamics Equilibrium via AMPK/SIRT1/FoxO1 Signal Pathways in Mice With Cerebral Ischemia Reperfusion,” CNS Neuroscience & Therapeutics 29, no. 9 (2023): 2583–2596.

[46] Chen M., Liu J., Wu W., et al., “SIRT1 restores Mitochondrial Structure and Function in Rats by Activating SIRT3 After Cerebral Ischemia/Reperfusion Injury,” Cell Biology and Toxicology 40, no. 1 (2024): 31.

[47] Zhou Z., Han V., and Han J., “New Components of the Necroptotic Pathway,” Protein & Cell 3, no. 11 (2012): 811–817.

[48] Cao Y., Chen S., Xiong X., Lin L., Wang W., and Wang L., “RIP1 Regulates Mitochondrial Fission During Skeletal Muscle Ischemia Reperfusion Injury,” Journal of Investigative Surgery 35, no. 6 (2022): 1269–1274.

[49] Wang S., Wang Y., Zhu H., Chen M., and Zhang L., “Gambogic Acid Inhibits Gastric Cancer Cell Proliferation Through Necroptosis,” Canadian Journal of Gastroenterology & Hepatology 2023 (2023): 7532367.

[50] Yu Y., Chen M., Guo Q., et al., “Human Umbilical Cord Mesenchymal Stem Cell Exosome-derived miR-874-3p Targeting RIPK1/PGAM5 Attenuates Kidney Tubular Epithelial Cell Damage,” Cellular & Molecular Biology Letters 28, no. 1 (2023): 12.

[51] Zhang J., Li X., Zhang Z., et al., “Role of the RIP3-PGAM5-Drp1 Pathway in Aluminum-induced PC12 Cells Necroptosis,” Ecotoxicology and Environmental Safety 270 (2024): 115860.

[52] Zhao M., Wang Y., Li L., et al., “Mitochondrial ROS Promote Mitochondrial Dysfunction and Inflammation in Ischemic Acute Kidney Injury by Disrupting TFAM-mediated mtDNA Maintenance,” Theranostics 11, no. 4 (2021): 1845–1863.

[53] Kaczmarek A., Vandenabeele P., and Krysko D. V., “Necroptosis: The Release of Damage-associated Molecular Patterns and Its Physiological Relevance,” Immunity 38, no. 2 (2013): 209–223.

[54] Li C. J., Lin L. T., Tsai H. W., Wen Z. H., and Tsui K. H., “Phosphoglycerate Mutase family Member 5 Maintains Oocyte Quality via Mitochondrial Dynamic Rearrangement During Aging,” Aging Cell 21, no. 2 (2022): e13546.

[55] Nag S., Szederkenyi K., Gorbenko O., Tyrrell H., Yip C. M., and McQuibban G. A., “PGAM5 is an MFN2 Phosphatase That Plays an Essential Role in the Regulation of Mitochondrial Dynamics,” Cell Reports 42, no. 8 (2023): 112895.

[56] Liu G., Chen H., Liu H., Zhang W., and Zhou J., “Emerging Roles of SIRT6 in human Diseases and Its Modulators,” Medicinal Research Reviews 41, no. 2 (2021): 1089–1137.

[57] Guo Z., Yu X., Zhao S., et al., “SIRT6 deficiency in Endothelial Cells Exacerbates Oxidative Stress by Enhancing HIF1α Accumulation and H3K9 Acetylation at the Ero1α Promoter,” Clinical and Translational Medicine 13, no. 8 (2023): e1377.

[58] Bandopadhyay S., Prasad P., Ray U., Das Ghosh D., and Roy S. S., “SIRT6 promotes Mitochondrial Fission and Subsequent Cellular Invasion in Ovarian Cancer,” FEBS Open Bio 12, no. 9 (2022): 1657–1676.

[59] Ding M., Feng N., Tang D., et al., “Melatonin Prevents Drp1-mediated Mitochondrial Fission in Diabetic Hearts Through SIRT1-PGC1α Pathway,” Journal of Pineal Research 65, no. 2 (2018): e12491.

[60] Hu L., Guo Y., Song L., et al., “Nicotinamide Riboside Promotes Mfn2-mediated Mitochondrial Fusion in Diabetic Hearts Through the SIRT1-PGC1α-PPARα Pathway,” Free Radical Biology and Medicine 183 (2022): 75–88.

[61] Marshall K. D. and Baines C. P., “Necroptosis: Is There a Role for Mitochondria?,” Frontiers in Physiology 5 (2014): 323.

[62] Zhou X., Hong Y., Chen J., et al., “The Necroptosis-mediated Imbalance of Mitochondrial Dynamics Is Involved in DEHP-induced Toxicity to Immature Testes via the PGAM5-DRP1 Interaction,” Environmental Pollution 346 (2024): 123585.

[63] Tresse E., Riera-Ponsati L., Jaberi E., Sew W. Q. G., Ruscher K., and Issazadeh-Navikas S., “IFN-β Rescues Neurodegeneration by Regulating Mitochondrial Fission via STAT5, PGAM5, and Drp1,” Embo Journal 40, no. 11 (2021): e106868.

[64] Yu B., Ma J., Li J., Wang D., Wang Z., and Wang S., “Mitochondrial Phosphatase PGAM5 Modulates Cellular Senescence by Regulating Mitochondrial Dynamics,” Nature Communications 11, no. 1 (2020): 2549.

[65] Lu W., Sun J., Yoon J. S., et al., “Mitochondrial Protein PGAM5 Regulates Mitophagic Protection Against Cell Necroptosis,” PLoS ONE 11, no. 1 (2016): e0147792.

[66] Longa E. Z., Weinstein P. R., Carlson S., and Cummins R., “Reversible Middle Cerebral Artery Occlusion Without Craniectomy in Rats,” Stroke; A Journal of Cerebral Circulation 20, no. 1 (1989): 84–91.

[67] Morris R., “Developments of a Water-maze Procedure for Studying Spatial Learning in the Rat,” Journal of Neuroscience Methods 11, no. 1 (1984): 47–60.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.